Skip to main content
. 2018 Mar 26;48(7):622–634. doi: 10.4070/kcj.2017.0362

Figure 5.

Figure 5

Antithormbotic therapy utilization based on income levels in AF patients presenting with a CHA2DS2-VASc score ≥2.

AF = atrial fibrillation; NOAC = non-vitamin K antagonist anticoagulant; WFR = warfarin.